|Traded as||FWB: SAZ|
|Hartmut Retzlaff (CEO and chairman of the executive board), Martin Abend (Chairman of the supervisory board)|
|Products||Generic and over-the-counter drugs|
|Revenue||€1.627 billion (2010)|
|€161.8 million (2010)|
|Profit||€68.4 million (2010)|
|Total assets||€2.507 billion (end 2010)|
|Total equity||€868.5 million (end 2010)|
Number of employees
|8,080 (FTE, average 2010)|
Commonly known products produced by Stada are Stada-brand acetaminophen and lactulose, Grippostad-C cold medicine and Ladival sun protection products. Stada- The Health Company is involved in various charity projects and sponsoring activities which include the support for dolphin aid e.V since 2007 and the support of a Romanian children's village in Timisoara.
Stada was founded in Dresden in 1895 as a cooperative pharmacy. Stada was originally an acronym for Standardarzneimittel Deutscher Apotheker (Standard Drugs (of) German Pharmacists). After World War II, the company was relocated to Essen and Tübingen. In 1956 it was moved again to Bad Vilbes and in 1970, Stada began trading on the stock exchange as a public company. At that time the shares were restricted to pharmacists as restrictedly transferable registered shares. Five years later, Stada entered the generic drug market. In 1986 Stada expanded internationally, buying companies in Switzerland and Austria. Soon after, it acquired foreign branches in the Netherlands and Belgium (1991), and then Asia (1992). In 1996 it acquired Aliud Pharma, expanding its reach into the French and Czech generic drugs markets. In 2001, the company began trading on the MDAX index. By 2006, it had made acquisitions in Denmark, Spain, Italy, Britain, Russia (Stada CIS) (Russian), Serbia, Portugal, and parts of Asia.
- "Annual Report 2010" (PDF). Stada Arzneimittel. Retrieved 13 April 2011.
|This German corporation or company article is a stub. You can help Wikipedia by expanding it.|